Filing Details

Accession Number:
0001213900-24-033121
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-15 21:15:05
Reporting Period:
2024-04-12
Accepted Time:
2024-04-15 21:15:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1769804 Augmedix Inc. AUGX Services-Business Services, Nec (7389) 833299164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826129 Ian Shakil C/O Augmedix, Inc.
111 Sutter Street, Suite 1300
San Francisco CA 94104
Chief Strategy Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-12 19,544 $0.86 22,544 No 4 M Direct
Common Stock Disposition 2024-04-12 19,544 $3.82 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-12 19,544 $0.00 19,544 $0.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
456,449 2028-12-05 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades ranging from $3.8000 to $3.9300. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. Fully vested.